Updated mini-review of the chemistry, pharmacology and validated assays for U.S. FDA approved COVID-19 therapeutic agents
<span>The fish market in Wuhan, China was the epicenter of Covid-19 pandemic, brought about by SARS-Co-V-2. The latter has radiated worldwide, resulting in significant economic and social disruption “Covid Crisis”. Although numerous drugs have been indicated for treating the viral infection...
Main Authors: | Miranda F. Kamal, Mohamed S. Nasr, Yousef S. Elshamy, Nehal W. El Sayed, Sara M. Mohyeldin |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy Publishing Center
2022-06-01
|
Series: | Advances in Medical, Pharmaceutical and Dental Research |
Subjects: | |
Online Access: | http://apc.aast.edu/ojs/index.php/AMPDR/article/view/449 |
Similar Items
-
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19
by: Jen-Yu Hsu, et al.
Published: (2021-09-01) -
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
by: Bhaswati Chatterjee, et al.
Published: (2022-05-01) -
Recent advances made in the synthesis of small drug molecules for clinical applications: An insight
by: Gunjan Arora, et al.
Published: (2021-01-01) -
Transient Leukopenia Induced by Combination Therapy for Severe SARS-CoV-2 Pneumonia
by: Sierra Sullivan, et al.
Published: (2022-10-01) -
Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
by: Rameez Hassan Pirzada, et al.
Published: (2021-04-01)